Kane Biotech Inc (KNE) — Free Cash Flow Generation Index
Latest as of June 2023:
0.85x
Kane Biotech Inc (KNE) has a Free Cash Flow Generation Index of 0.85x as of June 2023. Free cash flow of CA$323.73K represents 1% of operating cash flow (CA$382.38K). See KNE working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
0.85x
Free Cash Flow / Operating CF
Free Cash Flow
CA$323.73K
CAD
Operating Cash Flow
CA$382.38K
CAD
Capital Expenditures
CA$58.65K
CAD
Annual Free Cash Flow Generation for Kane Biotech Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Kane Biotech Inc. For the full company profile including market capitalisation, see Kane Biotech Inc (KNE) market capitalisation.
| Year | FCG Index | Free Cash Flow (CAD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).